Literature DB >> 23634180

Incidence and management of infections in patients with acute leukemia following chemotherapy in general wards.

Sasmita Biswal1, Chaitali Godnaik.   

Abstract

We hypothesise that treating patients with acute leukaemia in general wards, with proper hygienic and sanitary practices, would result in the minimum utilisation of resources as compared with the corresponding patients receiving ICU support. For this study, the acute leukaemia patients on induction chemotherapy were kept in general wards and observed for the incidence of neutropenia, resultant neutropenic febriles, the causative organism, and the effect of empirical antimicrobial treatment protocol on the outcome of such infections. Prophylactic anti-fungal therapy and cotrimoxazole therapy improved the outcome of infections. The therapy of neutropenic fever and infections must be adapted according to the risk factors and should include early empiric antifungal therapy. It was observed that the treatment of such patients in general wards could be managed effectively, with the added advantage of optimum utilisation of resources and in a patient-friendly environment, at a reasonable cost to the patients.

Entities:  

Keywords:  acute leukemia; febrile neutropenia; general ward setting; infection; mortality

Year:  2013        PMID: 23634180      PMCID: PMC3634721          DOI: 10.3332/ecancer.2013.310

Source DB:  PubMed          Journal:  Ecancermedicalscience        ISSN: 1754-6605


  39 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  The epidemiology of cancers of the upper alimentary and upper respiratory tracts.

Authors:  E L Wynder
Journal:  Laryngoscope       Date:  1978-01       Impact factor: 3.325

3.  Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever.

Authors:  H Giamarellou; H P Bassaris; G Petrikkos; W Busch; M Voulgarelis; A Antoniadou; E Grouzi; N Zoumbos
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

4.  Radioimmunoassay of human C-reactive protein and levels in normal sera.

Authors:  D R Claus; A P Osmand; H Gewurz
Journal:  J Lab Clin Med       Date:  1976-01

Review 5.  Infection in cancer patients. A continuing association.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

6.  A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer.

Authors:  Hugo R Paganini; Clarisa Aguirre; Gabriela Puppa; Cecilia Garbini; Javier Ruiz Guiñazú; Gabriela Ensinck; Claudia Vrátnica; Luis Flynn; Marisa Iacono; Pedro Zubizarreta
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

7.  C-reactive protein as an indicator of sepsis.

Authors:  P Póvoa; E Almeida; P Moreira; A Fernandes; R Mealha; A Aragão; H Sabino
Journal:  Intensive Care Med       Date:  1998-10       Impact factor: 17.440

8.  Intensive therapy for life-threatening medical complications of haematological malignancy.

Authors:  A R Lloyd-Thomas; H S Dhaliwal; T A Lister; C J Hinds
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

9.  Value of measurement of C-reactive protein in febrile patients with hematological malignancies.

Authors:  E Rintala; K Irjala; J Nikoskelainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

10.  Candidaemia and cancer: patients are not all the same.

Authors:  Alessandro Comarú Pasqualotto; Daniela Dornelles Rosa; Lidia Rosi Medeiros; Luiz Carlos Severo
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

View more
  8 in total

1.  Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.

Authors:  Weili Sun; Etan Orgel; Jemily Malvar; Richard Sposto; Jennifer J Wilkes; Rebecca Gardner; Vanessa P Tolbert; Alison Smith; Minjun Hur; Jill Hoffman; Susan R Rheingold; Michael J Burke; Alan S Wayne
Journal:  Pediatr Blood Cancer       Date:  2016-07-20       Impact factor: 3.167

2.  Surveillance Stool Culture and its Association with Microbiologically Documented Infection During Febrile Neutropenia in Patients with Acute Leukemia (AL) Undergoing Induction Chemotherapy.

Authors:  Naresh Jadhav; Jharna Mandal; Smita Kayal; Jogamaya Pattnaik; Ponraj Madasamy; Jagdeep Singh; Biswajit Dubashi
Journal:  Indian J Hematol Blood Transfus       Date:  2020-11-09       Impact factor: 0.915

3.  Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia-A Single Center Analysis.

Authors:  Franziska Modemann; Steffen Härterich; Julian Schulze Zur Wiesch; Holger Rohde; Nick Benjamin Lindeman; Carsten Bokemeyer; Walter Fiedler; Susanne Ghandili
Journal:  Antibiotics (Basel)       Date:  2022-01-19

4.  Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment.

Authors:  Susanne Ghandili; Philipp H von Kroge; Marcel Simon; Frank O Henes; Holger Rohde; Armin Hoffmann; Nick Benjamin Lindeman; Carsten Bokemeyer; Walter Fiedler; Franziska Modemann
Journal:  Cancers (Basel)       Date:  2022-06-02       Impact factor: 6.575

5.  Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital.

Authors:  Husnia Bedewi Mohammed; Malede Berihun Yismaw; Atalay Mulu Fentie; Tamrat Assefa Tadesse
Journal:  BMC Res Notes       Date:  2019-08-20

Review 6.  Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment.

Authors:  Bent-Are Hansen; Øystein Wendelbo; Øyvind Bruserud; Anette Lodvir Hemsing; Knut Anders Mosevoll; Håkon Reikvam
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-01-01       Impact factor: 2.576

7.  Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study.

Authors:  Arash Naeim; Maxwell Kroloff; Ramin Ramezani; Holly Wilhalme
Journal:  JMIR Form Res       Date:  2022-01-25

8.  Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood.

Authors:  David M Lowe; Julie Demaret; Nonzwakazi Bangani; Justine K Nakiwala; Rene Goliath; Katalin A Wilkinson; Robert J Wilkinson; Adrian R Martineau
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.